List of Medical Device Companies in Virginia - 6

Aretech is a world leader in developing advanced rehabilitation technologies for improving function and independence. We offer robotic body-weight support systems for a variety of therapy needs. Our technology includes ZeroG 3D, ZeroG, Ovation, and Luminaire. ZeroG 3D is a 3-Dimensional BWS System for multi-directional, unrestricted movement within a 3D workspace. The ZeroG Gait and Balance System is for gait and balance training along a custom designed ceiling track. Ovation is an interactive treadmill for patients up to 700 pounds to walk on a treadmill with motivating goals and metrics. Luminaire offers dynamic body-weight support over a slat-belt treadmill. All our products are hand-crafted in the United States and designed for durability with an emphasis on quality.

If it has to do with temperature measurement or calibration of temperature measurement equipment, EDL designs, engineers, manufactures,

With proven research capabilities across disciplines and applications, we develop technologies for mission-driven organizations, bringing high-impact solutions to life. From small-scale prototypes to market-ready products, our scientists and engineers leverage biotechnology, advanced materials, and engineered systems to create solutions that save time, save money, and save lives. We collaborate with the best companies, universities, and government labs in the world to explore the most promising new ideas and deliver transformative technologies to align with our customers' expectations. Our robust network of manufacturers, suppliers, licensees, and distributors extends our global impact. Biotechnology We solve complex healthcare challenges through applied R&D in wound mitigation, drug delivery, biosensors and wearables, point-of-care diagnostic platforms, and medical training tools. Core competencies: - Delivering the power of laboratory diagnostics to the field including POC ELISAs, dissolvable capture swabs, and automated spectrometry systems - Bio-interfacing technologies including nanofiber-based electrodes and quantitative ultrasound - Engineering biological responses to enhance wound care including adhesion barriers and nanofiber dressings for localized pain relief - Leveraging nanotechnology for advanced pharmaceutical design - Creating medical simulation tools for bleeding control and joint reduction Materials and Systems We specialize in cutting-edge research, development, and analysis for a wide range of applications including protective coatings, textiles, composites, electromagnetics, and corrosion monitoring and prevention. Core competencies: - Military-specific materials development - Advanced manufacturing techniques such as additive manufacturing and precision machining - Chemical and biological defense - Performance evaluation and testing - Lightweight materials and structures - Asset monitoring and non-destructive evaluation

RIVANNA® is elevating global standards of care through the development and commercialization of world-first imaging-based medical technologies, including BoneVision™ Multi-Probe Multi-Angle Image Acquisition, BoneEnhance® Multi-Frequency Image Reconstruction, and SpineNav3D™ AI-Enabled Spine Recognition. RIVANNA's complete clinician-assistance solutions improve decision-making, workflows, health outcomes, and patient satisfaction. Headquartered in Charlottesville, VA, RIVANNA is privately held and operates an FDA-registered and ISO 13485:2016 certified manufacturing facility. For more information, visit rivannamedical.com.

TearSolutions Inc. is a Delaware Corporation based in Charlottesville, VA. The company has successfully completed a well-powered 204 patient Phase II Proof of Concept clinical trial for the treatment of ocular surface disease in primary Sjögren’s Syndrome patients. Statistically significant improvement in both sign and symptom at two weeks was found. The trial compared vehicle and two doses of LacripepTM, a novel 19 AA peptide that is present in normal tears and deficient in all forms of dry eye. The peptide restores homeostasis to the ocular surface, in particular the barrier function of the corneal epithelium and normal function of sensory nerves at the corneal surface in preclinical animal models. Restoration of epithelial barrier function can be measured clinically as a decrease in corneal fluorescein staining while the improvement in sensory nerve function restores normal production of the components of tears: the aqueous via reinnervation of lacrimal glands, the lipid via reinnervation of meibomium glands and the mucin via reinnervation of goblet cells. Improvement in fluorescein staining and tear production (Schirmer tear test) are clinical ‘signs’ of ocular suface disease that have been used in the FDA approval of Xiidra and Restasis, respectively. Lacripep was discovered at the University of Virginia with NIH National Eye Institute funding as a naturally occurring fragment of the larger 119 AA protein, lacritin, in an unbiased screen for novel factors capable of addressing dry eye.

Medical & Aircraft Instruments